2026 HFM CME Symposium - Mineralocorticoid Receptor Antagonists in Heart Failure: The Evolving Treatment Landscape

HAZLET, N.J. - EntSun -- In this educational initiative, HF expert faculty members will explain the evidence with
sMRAs in HFrEF, discuss the limitations associated with utilization of sMRA therapy,
describe the distinct profiles of sMRAs and nsMRAs, and interpret clinical evidence with
sMRAs and nsMRAs in HFmrEF and HFpEF. A case study will provide attendees with best
practices in overcoming challenges of diagnosing HFpEF, identify "pillars" of therapy, and
describe keys to their effective and safe implementation.

Click here for more information

CHAIR

Javed Butler, MD, MPH, MBA
President, Baylor Scott & White Research Institute
Dallas, Texas
Distinguished Professor of Medicine

More on EntSun News

• Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
• For American Artist Appreciation Month (August): Check out a painting and a poem by Robert M. Barrows called "GOT THOSE STARVING ARTIST BLUES?"
• What's New in Hokkaido, Autumn 2026
• Antoine Maurice King's "New York Stand Up" Surpasses 10M TikTok Views
• MetroLagoons now accepting bookings for special events, holiday parties

University of Mississippi
Jackson, Mississippi

FACULTY

Stephen Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina

Muthiah Vaduganathan, MD, MPH
Co-Director, Center for Cardiometabolic Implementation Science
Assistant Professor of Medicine
Mass General Brigham and Harvard Medical School
Boston, Massachusetts

Orly Vardeny, PharmD, MS
Minneapolis VA Center for Care Delivery and Outcomes Research
Professor of Medicine
University of Minnesota
Minneapolis, Minnesota

Educational Objectives

• Describe the mechanisms of action of mineralocorticoid receptor antagonists (MRAs)
• Discuss the evidence for steroidal MRAs (sMRAs) in HFrEF and the challenges associated with their use
• Explain similarities and differences between nonsteroidal MRAs (nsMRAs) and sMRAs
• Interpret the clinical trial evidence for sMRAs and nsMRAs in patients with HFmrEF and HFpEF
• Indicate best practices for the diagnosis and treatment of patients with HFpEF

Target Audience

More on EntSun News

• The Competitive Advantage Isn't Automation. It's Having Lived
• CRG Awarded NASA SEWP VI Contracts in Categories B and C
• KLM Enterprises Services LLC Announces Company-Wide Adoption of ChatGPT and Codex
• The Railyard Event & Conference Center Opens Ticket Box Office in Downtown Elkins
• Heidi G. Villari of The Villari Firm, PLLC Named to Super Lawyers for the Tenth Consecutive Year

This program is intended for clinicians who manage patients with heart failure.

Accreditation and Credit Designation Statements
Voxmedia, LLC is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing
medical education for physicians.
Voxmedia, LLC designates this live activity for a maximum of
1.0 AMA PRA Category Credit(s)™. Physicians should claim
only the credit commensurate with the extent of their
participation in the activity.
Nurse practitioners may participate in this educational activity and earn a
certificate of completion as AANP accepts AMA PRA Category 1 Credits™
through its reciprocity agreements.
The National Commission on Certification of Physician Assistants accepts AMA
PRA Category 1 Credits™ from organizations accredited by the ACCME.